Japan approves dexamethasone as coronavirus treatment
Tokyo: Japan’s health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalised patients.
The ministry included dexamethasone as an option for treatment along with Gilead Sciences Inc’s antiviral drug remdesivir in a recent revision to its handbook.
BRICS condemns April 22 Pahalgam terror attack, calls for action against cross-border terrorism
Declaration says those involved in terror, their support networks must be held acc…
